Showing results (21-30 of 224) with videos related to
Sort By:
Pageof 23
Cornea|December 19, 2008
Infliximab for the treatment of refractory progressive sterile peripheral ulcerative keratitis associated with late corneal perforation: 3-year follow-upSilvia Odorcic, Edward C Keystone, Joseph J K MaACR Open Rheumatology|March 15, 2020
Modified Disease Activity Score at 3 Months Is a Significant Predictor for Rapid Radiographic Progression at 12 Months Compared With Other Measures in Patients With Rheumatoid ArthritisMohammad Movahedi, Deborah Weber, Pooneh Akhavan, et al.Arthritis and Rheumatism|September 2, 2006
Measuring function in rheumatoid arthritis: Identifying reversible and irreversible componentsDaniel Aletaha, Josef Smolen, Michael M WardArthritis Research & Therapy|June 16, 2006
Inhibition of protein geranylgeranylation induces apoptosis in synovial fibroblastsAlison M Connor, Stuart Berger, Aru Narendran, et al.Arthritis and Rheumatism|October 2, 2007
Disease activity early in the course of treatment predicts response to therapy after one year in rheumatoid arthritis patientsDaniel Aletaha, Julia Funovits, Edward C Keystone, et al.BMC Musculoskeletal Disorders|November 19, 2011
Safety and effectiveness of adalimumab in a clinical setting that reflects Canadian standard of care for the treatment of rheumatoid arthritis (RA): results from the CanACT studyBoulos Haraoui, Alfred Cividino, Jacqueline Stewart, et al.The Journal of Rheumatology|February 16, 2022
Physician- and Patient-reported Effectiveness Are Similar for Tofacitinib and TNFi in Rheumatoid Arthritis: Data From a Rheumatoid Arthritis RegistryMohammad Movahedi, Angela Cesta, Xiyuing Li, et al.Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|March 4, 2023
The Proportion of Patients With Rheumatoid Arthritis Achieving ACR20/50/70; Consistent Patterns of a 60/40/20 as Demonstrated by a Systematic Review and Meta-analysisAbir Mokbel, Mohammad Movahedi, Eleni Philippopoulos, et al.Rheumatology (Oxford, England)|December 11, 2019
Disease activity measures at baseline predict structural damage progression: data from the randomized, controlled AMPLE and AVERT trialsEdward C Keystone, Harris A Ahmad, Yusuf Yazici, et al.The Journal of Rheumatology|May 8, 2003
Therapeutic implications for interferon-alpha in arthritis: a pilot studyThomas Wong, Beata Majchrzak, Earl Bogoch, et al.Pageof 23